Health Ministry expands CDL Baghpat's veterinary vaccine testing to 42 vaccines
Synopsis
India's veterinary vaccine testing capacity just got a major upgrade. The Health Ministry has expanded the CCS-NIAH lab in Baghpat's mandate from 2 to 42 vaccines — covering diseases from Canine Distemper to Tetanus — a move that could cut regulatory timelines and boost India's standing as a global veterinary vaccine producer.
Key Takeaways
The Union Health and Family Welfare Ministry has amended the Drugs Rules, 1945 to expand CCS-NIAH Baghpat 's veterinary vaccine testing scope from 2 to 42 vaccines.
The gazette notification ( G.S.R.
65(E) ) is dated 28 January 2026 under the Drugs and Cosmetics Act, 1940 .
Vaccines now covered include those for Canine Distemper , Canine Coronavirus , Duck Plague , Fowl Pox , Salmonella , and Tetanus , among others.
The expansion is expected to ease import clearance and reduce testing turnaround time for veterinary vaccine manufacturers.
India is among the leading global producers of veterinary vaccines; the move is intended to strengthen national quality assurance infrastructure.
The Union Health and Family Welfare Ministry has notified amendments to the Drugs Rules, 1945, expanding the testing mandate of the Central Drugs Laboratory (CDL) at the Chaudhary Charan Singh-National Institute of Animal Health (CCS-NIAH), Baghpat, Uttar Pradesh, from just two veterinary vaccines to 42. The change, announced on Saturday, 20 June, is aimed at strengthening India's veterinary biological testing infrastructure, according to an official statement.
What Changed Under the Amendment
Prior to this notification, CCS-NIAH was authorised to test only two veterinary vaccines. The amended rules, notified vide Gazette Notification G.S.R. 65(E), dated 28 January 2026, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) under the provisions of the Drugs and Cosmetics Act, 1940, have now substantially broadened this scope.
The expanded list covers vaccines used in the prevention and control of diseases including Canine Distemper, Canine Coronavirus, Duck Plague, Fowl Pox, Salmonella, and Tetanus, among others. These vaccines address illnesses affecting dogs, horses, poultry, and other livestock.
Why This Matters for Animal Health and Trade
The enhanced testing capacity at CCS-NIAH is expected to facilitate smoother import procedures and faster regulatory clearance for veterinary biologicals. It will also significantly reinforce the national quality assurance system governing veterinary vaccines, according to the official statement.
Notably, the expanded mandate is projected to reduce testing timelines and improve turnaround time for manufacturers — a practical benefit for an industry where delays can affect the timely availability of critical vaccines. This comes amid growing recognition that animal health infrastructure directly impacts livestock productivity and rural livelihoods.
India's Position in Global Veterinary Vaccine Production
India is among the leading producers of veterinary vaccines globally. The expansion of testing facilities at CCS-NIAH is expected to support sector growth, promote the availability of quality-assured vaccines, and help safeguard animal health and livestock productivity across the country, the statement said.
The move is consistent with the government's broader effort to augment vaccine and biological testing capacity and strengthen the regulatory framework for quality, safety, and efficacy of veterinary products.
Regulatory Framework and Next Steps
The amendment has been issued under the Drugs and Cosmetics Act, 1940, giving it statutory force. Industry stakeholders are expected to benefit from reduced regulatory bottlenecks, particularly manufacturers seeking import clearances for veterinary biologicals. The strengthened framework at Baghpat positions CCS-NIAH as a more comprehensive national reference point for veterinary vaccine testing going forward.
Point of View
Forcing manufacturers into costly delays. The real measure of this amendment's impact will be turnaround time: if regulatory clearances for imports and domestic batches genuinely shorten, it could meaningfully reduce the gap between vaccine production and field availability. With livestock disease outbreaks periodically disrupting rural incomes, faster quality assurance is not just a regulatory upgrade — it is an animal husbandry and food security issue. The gazette date of January 2026 versus the June announcement also raises a quiet question about the pace of implementation communication.
NationPress
21 Jun 2026
Frequently Asked Questions
What has the Health Ministry changed regarding veterinary vaccine testing?
The Union Health and Family Welfare Ministry has amended the Drugs Rules, 1945 to allow the Central Drugs Laboratory at CCS-NIAH, Baghpat, Uttar Pradesh, to test 42 veterinary vaccines, up from just two previously. The change was notified via Gazette Notification G.S.R. 65(E) dated 28 January 2026.
Which diseases do the newly covered veterinary vaccines address?
The 42 vaccines now testable at CCS-NIAH include those targeting Canine Distemper, Canine Coronavirus, Duck Plague, Fowl Pox, Salmonella, and Tetanus, among others. They cover animals including dogs, horses, poultry, and other livestock.
Why is this expansion significant for manufacturers?
The expanded testing mandate at CCS-NIAH is expected to reduce testing timelines and improve turnaround time for manufacturers, while also facilitating easier import and regulatory clearance of veterinary biologicals in India.
Under which law has this amendment been issued?
The amendment has been issued under the Drugs and Cosmetics Act, 1940, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), giving it full statutory force.
How does this fit into India's broader veterinary vaccine landscape?
India is among the leading producers of veterinary vaccines globally. The expansion of testing facilities at CCS-NIAH is intended to support sector growth, strengthen quality assurance, and help ensure the timely availability of safe and effective veterinary vaccines across the country.
